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Chaperonin GroEL/GroES
Over-Expression Promotes
Aminoglycoside Resistance and
Reduces Drug Susceptibilities in
Escherichia coli Following Exposure
to Sublethal Aminoglycoside Doses
Lise Goltermann †‡, Menachem V. Sarusie †‡ and Thomas Bentin *
Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark
Antibiotic resistance is an increasing challenge to modern healthcare. Aminoglycoside
antibiotics cause translation corruption and protein misfolding and aggregation in
Escherichia coli. We previously showed that chaperonin GroEL/GroES depletion and
over-expression sensitize and promote short-term tolerance, respectively, to this drug
class. Here, we show that chaperonin GroEL/GroES over-expression accelerates
acquisition of streptomycin resistance and reduces susceptibility to several other
antibiotics following sub-lethal streptomycin antibiotic exposure. Chaperonin buffering
could provide a novel mechanism for emergence of antibiotic resistance.
Keywords: chaperonin, aminoglycosides, antibiotic resistance, protein misfolding, mRNA translation
INTRODUCTION
Chaperones comprise an integral part of the protein folding machinery of bacterial cells and
help maintain cellular homeostasis (Houry, 2001; Lin and Rye, 2006). Chaperones may also mask
deleterious effects of mutations (Rutherford and Lindquist, 1998). Chaperonin GroEL/GroES
promotes evolution of recombinant protein (Tokuriki and Tawfik, 2009) and a comparison of 446
bacterial genomes revealed that protein evolutionary rates in nature correlate positively with their
dependency on GroEL/GroES (Bogumil and Dagan, 2010). Aminoglycoside (AG) antibiotics are
known to promote translational misreading (Davies et al., 1964; Gorini and Kataja, 1964). Our lab
(Goltermann et al., 2013) and others (Ling et al., 2012) have demonstrated that AG action promotes
misfolding of newly synthesized protein. We have further demonstrated that GroEL/GroES over-
expression countered nascent protein misfolding and promoted bacterial survival and growth in
exponential cultures whereas chaperonin depletion sensitized cells to AG antibiotics (Goltermann
et al., 2013). Consistent with chaperones playing key roles in the response to AG antibiotics,
chaperone gene expression has been reported to be up-regulated in response to AG exposure across
different bacterial species (Lin et al., 2005; Kohanski et al., 2008; Cardoso et al., 2010). Although
not a mutagen in itself, the AG antibiotic streptomycin has been reported to induce mutations
via translational misreading in streptomycin sensitive (rpsL+) wild type E. coli (Boe, 1992) and
facilitate a mutator phenotype (Ren et al., 1999). Given that GroEL/GroES can promote short-term
tolerance to AG antibiotics (Goltermann et al., 2013) and that streptomycin has indirect mutagenic
properties (Boe, 1992; Ren et al., 1999), we speculated that chaperonin over-expression could buffer
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deleterious protein misfolding resulting from translational
misreading during AG exposure and hence promote adaptation
and resistance to AG antibiotics.
MATERIALS AND METHODS
Strains and Plasmids
We used E. coli strain MG1655 (a gift from Stanley Brown,
University of Copenhagen, strain #548 in our inventory)
transformed with pACYC184 derived plasmids with protein
expression driven by the arabinose inducible Pbad promoter.
The following plasmids were used: pGroEL/GroES (p544 in our
inventory) expressing GroEL/GroES, p1GroEL/GroES (p730-c1
in our inventory) deleted for the groS-groL genes (Goltermann
et al., 2013), and pGFP (p488-c1 in our inventory) expressing
GFPuv (Crameri et al., 1996) containing the F64L, S65T (Heim
et al., 1995; Cormack et al., 1996) mutations (Goltermann et al.,
2013). pGroEL/GroES is commercially available from Takara
Biosciences as pGro7 (Nishihara et al., 1998). The p730-c1 and
p488-c1 plasmids were previously described (Goltermann et al.,
2013). The construction of p730-c1 was erroneously described
and we therefore describe this plasmid in detail: Plasmid
p730-c1 (1GroEL/GroES) was generated by inverse PCR using
pGroEL/GroES as a template and 5′-phosphorylated primers
otb674 (5′P-TTGAGAAAGTCCGTATCTGTTATGGGTG) and
otb695 (5′P-GCCCTGCACCTCGCAGAAATAAAC). The PCR
product/template mix was DpnI treated to remove template. The
PCR amplicon was circularized with DNA ligase and transformed
into E. coli. The resulting construct was characterized by
restriction mapping using EcoRI and HindIII yielding bands
compatible with the expected fragment sizes (1947 and 1523 bp)
and by sequencing across the groS-groL deletion using otb710
(CAAAAGCGTACAGTTCAGGCG).
Susceptibility Assay and MIC Value
Determinations
Over-night MG1655/plasmid cultures in LB containing 40µg/ml
chloramphenicol (LBC; for plasmid maintenance) and 0.02%
L-arabinose (for GroEL/GroES induction) were diluted into fresh
LBC containing arabinose and sub-inhibitory concentrations
of selection antibiotic (12–14µg/ml streptomycin, 15µg/ml
spectinomycin, or 18µg/ml ampicillin (see Figure S1) followed
by continued growth over-night. Cultures were diluted to
OD595 nm = 0.003 in fresh medium, and the resulting cultures
were grown in Erlenmeyer flasks at 37◦C, 180 rpm ON. The
cultures were passaged every 24 h over the course of 3 days.
At each passage, aliquots of out-grown cultures were removed
normalized to 1 OD595 nm per ml and 100µl of undiluted
culture as well as ten-fold dilutions were plated on LBC-agar
containing inhibitory amounts of selection antibiotic (40µg/ml
streptomycin, 80µg/ml spectinomycin, or 60µg/ml ampicillin)
to determine the number of resistant colony forming units
(cfu), and on LBC-agar to determine the total cfu count. Drug
tolerant cfu and total cfu were thus determined on plates without
L-arabinose. Growth inhibitory concentrations of selection
antibiotic were determined as the concentration that did not
allow visible growth following 24 h incubation at 37◦C of an
unexposed culture. Following over-night incubation, cfu were
counted manually. Examples of colonies growing on inhibitory
selection antibiotic (streptomycin) were re-streaked on fresh
plates to determine whether the reduced drug susceptibility
was stably inherited. Drug susceptibility to streptomycin and
other antibiotics was investigated further by growth in LBC
liquid culture using microtiter plates and using the indicated
antibiotic concentrations (Table 1). MIC determinations were
done by replica plating from a fresh over-night culture using
a 48-pin tool (frogger) into 200µl of LBC and the desired
test antibiotic (Table 2). Plates were double taped to avoid
evaporation and scored for ±growth after over-night incubation
at 37◦C at 900 rpm in a Heidolph microplate incubator.
Sequencing of the chromosomal rpsL gene in streptomycin
resistant isolates was done using primer otb722 following PCR
amplification of the rpsL locus using forward primer otb721
(TCTGCGTAATGCCCCCATTAAGG) and reverse primer
otb722 (AACTTCGGATCCGGCAGAATTTTAC).
RESULTS AND DISCUSSION
In order to determine whether GroEL/GroES over-expression
promotes resistance to AG antibiotics, we examined drug
susceptibilities of MG1655 over-expressing the chaperonin
complex following exposure to sub-lethal concentrations
TABLE 1 | Susceptibility to other antibiotics of streptomycin selected
isolates.
pGroEL/GroES p1GroEL/GroES
Streptomycin 100% (95/95) 100% (127/127)
Ampicillin 15% (14/95) 2% (3/127)
Tetracycline 0% (0/95) 0% (0/127)
Spectinomycin 19% (18/95) 3% (4/127)
Kanamycin 9% (9/95) 1% (1/127)
Amp/Spc/Str 5% (5/95) 0 (0/127)
Spc/Kan/Str 4% (4/95) 0 (0/127)
Sensitivity to other antibiotics of isolates growing on inhibitory streptomycin plates
from pGroEL/GroES and p1GroEL/GroES transformed MG1655 cultures after 24 h of
sub-inhibitory streptomycin selection. Streptomycin, Str (100µg/ml), Ampicillin, Amp
(100µg/ml), Tetracycline (10µg/ml), Spectinomycin, Spc (50µg/ml, Spc), Kanamycin,
Kan (50µg/ml, Kan).
TABLE 2 | MIC values of streptomycin selected pGroEL/GroES isolates.
Control Isolates
Streptomycin (µg/ml) 4 ≥128
Kanamycin (µg/ml) 8 128
Spectinomycin (µg/ml) 16 64
Ampicillin (µg/ml) 16 64
Tetracycline (µg/ml) 2 2
“Isolates” and “Control” designate pGroEL/GroES MG1655 cultures that had or had not
been exposed to streptomycin selection prior toMIC determination, respectively. Numbers
are based on the experiment shown in Table S2.
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of various “selection antibiotics”: (i) Streptomycin, an
aminoglycoside causing ribosomal misreading and protein
misfolding, (ii) spectinomycin, a bacteriostatic antibiotic that
causes translational blockage without misreading or protein
misfolding, and (iii) ampicillin, which targets the peptidoglycan
layer and therefore is not expected to impact protein folding.
The antibiotic concentrations used were based on a titration,
which showed similar growth phenotypes among the differently
used antibiotics (Figure S1). We used the E. coli strain MG1655
transformed with one of three arabinose inducible plasmids.
One transformant contained the plasmid pGroEL/GroES
(Nishihara et al., 1998) expressing chaperonin GroEL/GroES. As
controls, we used MG1655 transformed with p1GroEL/GroES
in which the entire groS-groL coding region was deleted (empty
control) and MG1655 transformed with pGFP, a plasmid that
expresses GFP (over-expression control). Cultures were passaged
with arabinose inducer for 3 days in total (Figure S2) and
drug susceptibility was then determined without chaperonin
induction.
The pGroEL/GroES transformed strain showed a rapid
reduction of drug susceptibility following streptomycin
selection as determined by the percentage of cfu growing on
plates containing an inhibitory streptomycin concentration
(Figure 1A). In fact, the pGroEL/GroES transformed culture
was virtually purged for streptomycin sensitive bacteria in
only 3 days. MG1655 transformed with p1GroEL/GroES
also showed reduced drug susceptibility following growth in
sub-lethal streptomycin but this was much less pronounced
requiring extended exposure (Figure 1A). This tendency also
holds true in absolute numbers (Figure S3B), even though the
pGroEL/GroES transformed strain grew to a lower cell density
on day 1 of selection (see legend to Figure S2). Similar to the
p1GroEL/GroES transformed strain, streptomycin tolerance
in MG1655/pGFP also developed slowly (Figure S3), indicating
that protein over-expression in itself did not enhance antibiotic
adaptation. We conclude that acceleration of adaptation toward
streptomycin was a result of chaperonin action.
Colonies derived following sub-lethal streptomycin selection
and growth on inhibitory streptomycin plates, were incubated
in liquid culture containing 100µg/ml streptomycin and all
showed growth (Table 1). This suggests that these colonies were
not only temporarily tolerant but heritably resistant toward
streptomycin.
Among the 95 chaperonin over-expressing isolates, 17
randomly selected colonies from the first day of selection were
sequenced for changes in the rpsL gene encoding ribosomal
protein S12. Mutations in the S12 protein that confer resistance
to streptomycin are known. Two independent point mutations
giving rise to an arginine to serine mutation at codon 85 (R85S)
and a lysine to arginine mutation at codon 87 (K87R) were found
(Table S1). A streptomycin sensitive control, which had not been
exposed to streptomycin selection, was sequenced and revealed
the wild type rpsL gene sequence (Table S1). The K87R mutation
confers resistance to streptomycin (Timms et al., 1992). We have
not found a prior description of the specific R85S mutation.
These observations show that GroEL/GroES over-expression
can enable accelerated resistance acquisition during sub-lethal
streptomycin selection and that this resistance is genetically
based.
A number of resistant isolates identified on day 1 after
streptomycin or ampicillin selection were tested for susceptibility
to other antibiotics at or above the MIC value of the
parent strain (Table 1). Interestingly, several pGroEL/GroES
isolates resistant to streptomycin were found to show reduced
susceptibility to one (ampicillin, spectinomycin, or kanamycin)
or two (spectinomycin and kanamycin or spectinomycin and
FIGURE 1 | Chaperonin dependent antibiotic resistance development following sub-inhibitory selection. Percentage of colonies growing on inhibitory
concentrations of the indicated antibiotics used for selection with or without over-expression of GroEL/GroES (pGroEL/GroES), or an empty control plasmid
(p1GroEL/GroES). The number of cfu growing on inhibitory antibiotic plates was normalized to total cfu count (Each data point consists of 2-4 experimental repeats
each composed of 2-4 technical repeats. Error bars show SD). Day 1: pGroEL/GroES vs. p1GroEL/GroES p < 0.0001 (***), day 2: pGroEL/GroES vs.
p1GroEL/GroES p < 0.0001 (***), day 3: pGroEL/GroES vs. p1GroEL/GroES p < 0.0001 (***). Note the split y-axis used to enable visualization of large differences
within the same graph. (A) Str, streptomycin; (B) Spc, spectinomycin; (C) Amp, ampicillin.
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ampicillin) additional antibiotics. Susceptibility to tetracycline
was unaltered.
To explore drug susceptibilities further, we repeated the
selection experiment in sub-lethal streptomycin concentrations
and picked fresh pGroEL/GroES isolates growing on inhibitory
streptomycin plates. These isolates were grown ON in a 96
well format. We then determined MIC values by replica plating
and growth ON in media (Table 2; Table S2). Compared to the
control (included in duplicate), which had not been subjected
to selection, isolates were observed to show reduced drug
susceptibilities to streptomycin (as expected), to kanamycin, and
to a lesser extent to spectinomycin and ampicillin. As above,
tetracycline sensitivity was unaltered. MIC values are known to
be sensitive to the inoculum density and since these isolates were
inoculated using a pin tool (Table S2) whereas the data presented
in Table 1 was obtained following inoculation of cfu, we did
not expect identical numbers. Nevertheless, we observe a clear
trend that isolates over-expressing GroEL/GroES during growth
with sub-lethal streptomycin exposure rapidly acquired reduced
susceptibility to the selection drug and also to additional drugs.
Selection with spectinomycin resulted in a very low fraction
of colonies showing reduced susceptibility to the drug even after
3 days of selection, regardless of chaperonin status (Figure 1B).
Cultures grown without antibiotic selection did not yield
any colonies under any of the tested conditions indicating
that spontaneous formation of resistant isolates w/o antibiotic
selection was under our detection limit (estimated to be ∼1 cfu
in 108 cells).
Selection with ampicillin produced only few colonies showing
reduced ampicillin susceptibility (Figure 1C), and only 1–4%
of these isolates showed reduced susceptibility to an additional
antibiotic (Table S3). Unexpectedly, the pGroEL/GroES
transformed strain showed a small but significant reduction of
susceptibility to ampicillin as compared to MG1655 harboring
p1GroEL/GroES (Figure 1C) even though ampicillin action
targets the peptidoglycan layer and does not involve protein
misfolding. We do not know the mechanism(s) connecting
chaperonin over-expression to reduced ampicillin susceptibility.
One speculative mechanism could involve GroEL/GroES
dependent accelerated protein evolution, as described for
GroES/GroEL substrates in vitro (Tokuriki and Tawfik,
2009) and in vivo (Bogumil and Dagan, 2010). To this end,
GroEL/GroES is a known cytosolic chaperone, but it nevertheless
does interact with a few membrane proteins (Kerner et al., 2005)
and could chaperone a wider collection of proteins than those
identified by interaction analyses (Chapman et al., 2006).
We repeated the selection experiment using two other
AG antibiotics: Kanamycin and gentamicin (Figure S4).
Resistance toward these antibiotics occurs infrequently as
compared with streptomycin. Nevertheless, like in the case of
streptomycin, GroEL/GroES over-expressing bacteria grown
under sub-inhibitory kanamycin (14µg/ml) or gentamicin
(1.5µg/ml) concentrations showed more colonies on inhibitory
plates as compared with the 1GroEL/GroES strain following
plating on plates containing 60µg/ml kanamycin or 10µg/ml
gentamicin, respectively. Compared to the streptomycin
selection experiment, colonies from kanamycin or gentamicin
selection were smaller indicating slower growth. The observation
that more cfu grew following selection with GroEL/GroES over-
expression, however, suggests that chaperonin over-expression
also promotes reduced drug susceptibilities to these members of
the AG class of antibiotics.
The present results reveal that chaperonin action can
accelerate resistance development to streptomycin following
exposure to sub-lethal streptomycin concentrations and
simultaneously reduce drug susceptibilities to other antibiotics
to which the bacteria had not previously been exposed. These
observations are compatible with chaperonin over-expression
conferring an increased fitness due to reduced protein misfolding
during exposure to AG. In turn, this enables selection for reduced
drug susceptibility, which is accelerated due to the mutator
phenotype resulting from streptomycin exposure (Ren et al.,
1999). Such selected strains would also have acquired numerous
additional mutations. Mutations reducing influx or increasing
efflux (Pagès et al., 2008; Nikaido and Pagès, 2012) could explain
reduced susceptibility to multiple antibiotics.
Together, the results suggest that chaperonins could enable
formation of complex antibiotic susceptibility phenotypes
from a single AG exposure regime. We propose a model,
where GroEL/GroES over-expression reduce protein
misfolding, increase fitness, expand the “mutational space,”
and provide a window of opportunity for bacteria to acquire
resistance or tolerance and hence evade drug mediated
killing.
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